Phase 2 Trial Of Pembrolizumab (Pem) Plus Granulocyte Macrophage Colony Stimulating Factor (Gm-Csf) In Advanced Biliary Cancers (Abc): Clinical Outcomes And Biomarker Analyses.
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要